Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20b39cf09154f0ba37d2bbdac2261c78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3307f8a72c8c008ae0b440110327163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_058a6aadbbc510b897bccd20af10541a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0318 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-13098 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
filingDate |
2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca2fe2e367cd76ef7961dcea7df818e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91178bc6dfd5a2216c90e09229105c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7181c3f4c01dcaf84c77924c2d95213a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f2926f6bd485af9aaa6311dca1570ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b94997257ad827b7f8426953e475c5 |
publicationDate |
2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018138371-A1 |
titleOfInvention |
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias |
abstract |
The present invention relates to a vector for use in the treatment of a polyglutamine repeat spinocerebellar ataxia, which vector comprises cholesterol 24-hydroxylase encoding nucleic acid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4205757-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020089154-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020234363-A3 |
priorityDate |
2017-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |